Media coverage
5
Media coverage
Title Research results: OliX Pharmaceuticals announces positive results of phase 1 safety and tolerability results of OLX10212 for AMD Media name/outlet Ophthalmology Times Europe Country/Territory United Kingdom Date 23.12.13 URL https://europe.ophthalmologytimes.com/view/research-results-olix-pharmaceuticals-announces-positive-results-of-phase-1-safety-and-tolerability-results-of-olx10212-for-amd Persons Kichang Lee Title OliX Pharmaceuticals announces positive results of phase 1 safety and tolerability results of OLX10212 for AMD Media name/outlet Samachar Central Country/Territory India Date 23.12.13 URL https://samacharcentral.com/olix-pharmaceuticals-announces-positive-results-of-phase-1-safety-and-tolerability-results-of-olx10212-for-amd/ Persons Kichang Lee Title Positive results announced in phase 1 safety and tolerability study of OLX10212 Media name/outlet Optometry Times Country/Territory United States Date 23.12.13 URL https://www.optometrytimes.com/view/positive-results-announced-in-phase-1-safety-and-tolerability-study-of-olx10212 Persons Kichang Lee Title OliX Pharmaceuticals announces positive results of phase 1 study of safety and tolerability of OLX10212; The study saw encouraging results and helped to identify suitable dosing levels for future clinical trials. Media name/outlet Modern Retina Country/Territory United States Date 23.12.12 Persons Kichang Lee Title Research results: OliX Pharmaceuticals announces positive results of phase 1 safety and tolerability results of OLX10212 for AMD Media name/outlet Ophthalmology Times Europe Country/Territory United Kingdom Date 23.12.1 Persons Kichang Lee